Search research articles
Contact Us
Filters
Showing results (61-70 of 266) with videos related to
Page
of 27
Sort By:
Expert Review of Cardiovascular Therapy
|
February 7, 2025
Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence)
Manuel Anguita, Francisco Marín, Javier Soto, et al.
Journal of Clinical Medicine
|
October 23, 2021
Association of the KDIGO Risk Classification with the Prevalence of Heart Failure in Patients with Type 2 Diabetes
José Antonio Gimeno-Orna, Luis Rodríguez-Padial, Manuel Anguita-Sánchez, et al.
Cardiology Journal
|
March 10, 2023
Characteristics of women with type 2 diabetes and heart failure in Spain. The DIABET-IC study
Luis Rodríguez-Padial, Antonio Pérez, Manuel Anguita Sánchez, et al.
Revista Espanola De Cardiologia (English Ed.)
|
May 3, 2023
30-day readmissions for circulatory system diseases in patients over 75 years with heart failure in Spain (2016-2018)
Alberto Esteban-Fernández, Manuel Anguita-Sánchez, María Anguita-Gámez, et al.
Journal of Psychiatric Research
|
November 11, 2009
Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis
María L Barrigón, Manuel Gurpegui, Miguel Ruiz-Veguilla, et al.
Revista Espanola De Cardiologia (English Ed.)
|
April 23, 2019
Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?
Iñaki Lekuona, Manuel Anguita, José Luis Zamorano, et al.
Revista Espanola De Cardiologia
|
February 10, 2007
[How many patients admitted for heart failure are eligible for cardiac resynchronization therapy? Analysis of the Andalusian Heart Failure Registry (RAIC) study]
José M García-Pinilla, Manuel F Jiménez-Navarro, Manuel Anguita-Sánchez, et al.
Journal of Comparative Effectiveness Research
|
March 31, 2021
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)
Marcelo Sanmartín Fernández, Francisco Marín, Carles Rafols, et al.
Revista Espanola De Cardiologia (English Ed.)
|
May 12, 2015
Organization of Heart Failure Care in Spain: Characteristics of Heart Failure Units
Alfonso Castro-Beiras, Manuel Anguita-Sánchez, Josep Comín, et al.
Frontiers in Plant Science
|
February 11, 2020
Culture-Dependent and Culture-Independent Characterization of the Olive Xylem Microbiota: Effect of Sap Extraction Methods
Manuel Anguita-Maeso, Concepción Olivares-García, Carmen Haro, et al.
Page
of 27
Search research articles
Search
Showing results (61-70 of 266) with videos related to
Sort By:
Page
of 27
Expert Review of Cardiovascular Therapy
|
February 7, 2025
Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence)
Manuel Anguita, Francisco Marín, Javier Soto, et al.
Journal of Clinical Medicine
|
October 23, 2021
Association of the KDIGO Risk Classification with the Prevalence of Heart Failure in Patients with Type 2 Diabetes
José Antonio Gimeno-Orna, Luis Rodríguez-Padial, Manuel Anguita-Sánchez, et al.
Cardiology Journal
|
March 10, 2023
Characteristics of women with type 2 diabetes and heart failure in Spain. The DIABET-IC study
Luis Rodríguez-Padial, Antonio Pérez, Manuel Anguita Sánchez, et al.
Revista Espanola De Cardiologia (English Ed.)
|
May 3, 2023
30-day readmissions for circulatory system diseases in patients over 75 years with heart failure in Spain (2016-2018)
Alberto Esteban-Fernández, Manuel Anguita-Sánchez, María Anguita-Gámez, et al.
Journal of Psychiatric Research
|
November 11, 2009
Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis
María L Barrigón, Manuel Gurpegui, Miguel Ruiz-Veguilla, et al.
Revista Espanola De Cardiologia (English Ed.)
|
April 23, 2019
Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?
Iñaki Lekuona, Manuel Anguita, José Luis Zamorano, et al.
Revista Espanola De Cardiologia
|
February 10, 2007
[How many patients admitted for heart failure are eligible for cardiac resynchronization therapy? Analysis of the Andalusian Heart Failure Registry (RAIC) study]
José M García-Pinilla, Manuel F Jiménez-Navarro, Manuel Anguita-Sánchez, et al.
Journal of Comparative Effectiveness Research
|
March 31, 2021
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)
Marcelo Sanmartín Fernández, Francisco Marín, Carles Rafols, et al.
Revista Espanola De Cardiologia (English Ed.)
|
May 12, 2015
Organization of Heart Failure Care in Spain: Characteristics of Heart Failure Units
Alfonso Castro-Beiras, Manuel Anguita-Sánchez, Josep Comín, et al.
Frontiers in Plant Science
|
February 11, 2020
Culture-Dependent and Culture-Independent Characterization of the Olive Xylem Microbiota: Effect of Sap Extraction Methods
Manuel Anguita-Maeso, Concepción Olivares-García, Carmen Haro, et al.
Page
of 27